UNSPSC 51422105: Fluocortin

This classification denotes a dermatologic agent and glucocorticoid with the molecular formula C22H27FO5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 03837V0H1Y, chemically known as pregna-1,4-dien-21-oic acid, 6-fluoro-11-hydroxy-16-methyl-3,20-dioxo-, (6alpha,11beta,16alpha)- but generally known as fluocortin, which bears US NIH Compound Identifier 118029. European Medicines Agency schedules Fluocortin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07716MIG.

UNSPSC 51422105 Fluocortin is a Commodity code that does not align with the recent state and local opportunities posted under this classification. The two most recent solicitations tagged to this code — a Seminole County, Florida naloxone and drug deactivation systems procurement (IFB, due July 26, 2023) and a Texas Health and Human Services Commission request for information on direct-to-manufacturer prescription programs (RFI, due April 3, 2026) — address pharmaceutical supply chains and opioid-response products, not the specific steroid compound the code nominally describes. The mismatch between the code name and actual procurement activity suggests either data-entry error in the tagging or significant drift between the code's intended scope and how state and local procurement offices are applying it in practice.

The limited recent activity and thematic disconnection make this code difficult to characterize as a reliable signal for business development. If you are selling naloxone, drug deactivation systems, or direct pharmaceutical supply solutions, these opportunities merit pursuit on their substantive merits — Seminole County's standing annual requirement (1,900 units of naloxone and 800 deactivation systems) with quarterly delivery cycles offers recurring revenue potential, and Texas HHS's exploratory RFI phase suggests a formalized RFP may follow once the state completes its vendor research. However, prospecting under UNSPSC 51422105 itself carries execution risk; confirm the code alignment with the issuing agency before investing pre-bid effort.